Targeting Longevity Gene <i>SLC13A5</i>: A Novel Approach to Prevent Age-Related Bone Fragility and Osteoporosis
Reduced expression of the plasma membrane citrate transporter <i>SLC13A5</i>, also known as INDY, has been linked to increased longevity and mitigated age-related cardiovascular and metabolic diseases. Citrate, a vital component of the tricarboxylic acid cycle, constitutes 1–5% of bone w...
Main Authors: | Grit Zahn, Hannes A. Baukmann, Jasmine Wu, Jens Jordan, Andreas L. Birkenfeld, Naomi Dirckx, Marco F. Schmidt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/13/12/1186 |
Similar Items
-
A Novel and Cross-Species Active Mammalian INDY (NaCT) Inhibitor Ameliorates Hepatic Steatosis in Mice with Diet-Induced Obesity
by: Grit Zahn, et al.
Published: (2022-08-01) -
Growth and Overall Health of Patients with <i>SLC13A5</i> Citrate Transporter Disorder
by: Tanya L. Brown, et al.
Published: (2021-10-01) -
Characterizing a rare neurogenetic disease, SLC13A5 citrate transporter disorder, utilizing clinical data in a cloud-based medical record collection system
by: Emily M. Spelbrink, et al.
Published: (2023-03-01) -
Mapping the Metabolic Niche of Citrate Metabolism and <i>SLC13A5</i>
by: Fangfang Chen, et al.
Published: (2023-02-01) -
The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug development
by: Dipender Gill, et al.
Published: (2023-12-01)